學術產出-學位論文

文章檢視/開啟

書目匯出

Google ScholarTM

政大圖書館

引文資訊

TAIR相關學術產出

題名 百略醫學科技股份有限公司:國際品牌、品牌策略個案研究
作者 羅綠楊
貢獻者 白德傑
羅綠楊
關鍵詞 百略醫學科技股份有限公司
日期 2007
上傳時間 14-九月-2009 09:54:03 (UTC+8)
摘要 百略醫學科技股份有限公司:國際品牌、品牌策略個案研究
Abstract
     
     Microlife Corporation: A Globalizing Brand
     By
     Gerald A. Roliz
     
      Microlife Corporation engages in the development and manufacturing of medical diagnostic equipment for institutional and home use worldwide. Their primary product offering includes blood pressure monitors, digital thermometers, and asthma monitors. All hardware products primarily reach end users through the retail channel, while pressure on contribution margins constantly grows due to increased competition.
      The product pipeline for Microlife Corporation is quite prolific and includes 2 product lines that are set for imminent launch and will be distributed to a new target market that is unfamiliar with the Microlife brand. The senior executives of Microlife Corporation Kin Yuan Lin, Ty-minh Tan, and Scot Muve must decide on how to proceed with the firm’s brand strategy development. The transfer of existing brand equity from the retail channel into the professional channel remains an issue and requires considerable discussion.
      Furthermore, the medical device industry is spawning new innovations, which leads to new developments of medical technologies. Earlier detection of diseases, digitalization of data, and secure transmission of information among healthcare professionals are developing trends.
      To keep up with the evolution of the medical device industry’s new medical technologies, Microlife Corporation acquired and created 2 new product lines. Both are in pre-launch phase and proven to successfully integrate medical hardware devices with functional software solutions. The Microlife Medical Home Solutions (MiMHS) subsidiary functions as the research arm for workflow solutions, software platforms, and patient positive outcome guidelines for physician clinics. The Microlife executives foresee healthcare systems in many countries will gradually shift toward pay-for-performance reimbursement systems. Both patients and tending physicians will be held more accountable for healthcare fees and reimbursement in the future.
      Microlife Corporation contracted Direction Design Group to assist in the remodeling of their existing Corporate Identity and to assist in brand strategy development for the future product offerings that will ensure Microlfe Corporation’s customers continue to recognize, understand, and believe in the Microlife brand.
     Microlife. A partner for people. For life.
TABLE OF CONTENTS
     Abstract ………………………………………………………………………… iii
     Acknowledgements …………………………………………………………… v
     Table of Contents ……………………………………………………………… vi
     1. Story Introduction ……………………………………………………………. 1
     2. Company Background ..……………………………………………………… 2
     3. The Medical Device Industry ...……………………………………………… 2
     3.1 Industry Investment ……………………………………………………. 3
     3.2 Increasing Costs ……………………………………………………….. 4
     3.3 Reimbursement Challenges ……………………………………………. 4
     3.4 Technology Guided Evolution of Healthcare ………………………….. 5
     4. Third Generation Product Lines ……………………………………………... 6
     5. Advanced Medical Home ……………………………………………………. 7
     6. Meeting Break ……………………………………………………………….. 7
     7. The Current Microlife Corporate Brand …………………………………… 8
     7.1 Brand Management .………………………………………………….. 9
     7.2 Centralized control over Global Branding ……………………………. 10
     8. DDG | Direction Design Group LLC, Taiwan Branch ……………………… 10
     8.1 Physician feedback .…………………………………………………. 11
     9. The Next Step | WatchBP …………………………………………………… 12
     10. Discussion Questions ………………………………………………………... 14
     11. Exhibits ...………………………………………………………………….. 15
     12. Final Outcome ……………………………………………………………... 20
參考文獻 none
描述 碩士
國立政治大學
國際經營管理碩士班(IMBA)
95933029
96
資料來源 http://thesis.lib.nccu.edu.tw/record/#G0959330291
資料類型 thesis
dc.contributor.advisor 白德傑zh_TW
dc.contributor.author (作者) 羅綠楊zh_TW
dc.creator (作者) 羅綠楊zh_TW
dc.date (日期) 2007en_US
dc.date.accessioned 14-九月-2009 09:54:03 (UTC+8)-
dc.date.available 14-九月-2009 09:54:03 (UTC+8)-
dc.date.issued (上傳時間) 14-九月-2009 09:54:03 (UTC+8)-
dc.identifier (其他 識別碼) G0959330291en_US
dc.identifier.uri (URI) https://nccur.lib.nccu.edu.tw/handle/140.119/31383-
dc.description (描述) 碩士zh_TW
dc.description (描述) 國立政治大學zh_TW
dc.description (描述) 國際經營管理碩士班(IMBA)zh_TW
dc.description (描述) 95933029zh_TW
dc.description (描述) 96zh_TW
dc.description.abstract (摘要) 百略醫學科技股份有限公司:國際品牌、品牌策略個案研究zh_TW
dc.description.abstract (摘要) Abstract
     
     Microlife Corporation: A Globalizing Brand
     By
     Gerald A. Roliz
     
      Microlife Corporation engages in the development and manufacturing of medical diagnostic equipment for institutional and home use worldwide. Their primary product offering includes blood pressure monitors, digital thermometers, and asthma monitors. All hardware products primarily reach end users through the retail channel, while pressure on contribution margins constantly grows due to increased competition.
      The product pipeline for Microlife Corporation is quite prolific and includes 2 product lines that are set for imminent launch and will be distributed to a new target market that is unfamiliar with the Microlife brand. The senior executives of Microlife Corporation Kin Yuan Lin, Ty-minh Tan, and Scot Muve must decide on how to proceed with the firm’s brand strategy development. The transfer of existing brand equity from the retail channel into the professional channel remains an issue and requires considerable discussion.
      Furthermore, the medical device industry is spawning new innovations, which leads to new developments of medical technologies. Earlier detection of diseases, digitalization of data, and secure transmission of information among healthcare professionals are developing trends.
      To keep up with the evolution of the medical device industry’s new medical technologies, Microlife Corporation acquired and created 2 new product lines. Both are in pre-launch phase and proven to successfully integrate medical hardware devices with functional software solutions. The Microlife Medical Home Solutions (MiMHS) subsidiary functions as the research arm for workflow solutions, software platforms, and patient positive outcome guidelines for physician clinics. The Microlife executives foresee healthcare systems in many countries will gradually shift toward pay-for-performance reimbursement systems. Both patients and tending physicians will be held more accountable for healthcare fees and reimbursement in the future.
      Microlife Corporation contracted Direction Design Group to assist in the remodeling of their existing Corporate Identity and to assist in brand strategy development for the future product offerings that will ensure Microlfe Corporation’s customers continue to recognize, understand, and believe in the Microlife brand.
     Microlife. A partner for people. For life.
en_US
dc.description.abstract (摘要) TABLE OF CONTENTS
     Abstract ………………………………………………………………………… iii
     Acknowledgements …………………………………………………………… v
     Table of Contents ……………………………………………………………… vi
     1. Story Introduction ……………………………………………………………. 1
     2. Company Background ..……………………………………………………… 2
     3. The Medical Device Industry ...……………………………………………… 2
     3.1 Industry Investment ……………………………………………………. 3
     3.2 Increasing Costs ……………………………………………………….. 4
     3.3 Reimbursement Challenges ……………………………………………. 4
     3.4 Technology Guided Evolution of Healthcare ………………………….. 5
     4. Third Generation Product Lines ……………………………………………... 6
     5. Advanced Medical Home ……………………………………………………. 7
     6. Meeting Break ……………………………………………………………….. 7
     7. The Current Microlife Corporate Brand …………………………………… 8
     7.1 Brand Management .………………………………………………….. 9
     7.2 Centralized control over Global Branding ……………………………. 10
     8. DDG | Direction Design Group LLC, Taiwan Branch ……………………… 10
     8.1 Physician feedback .…………………………………………………. 11
     9. The Next Step | WatchBP …………………………………………………… 12
     10. Discussion Questions ………………………………………………………... 14
     11. Exhibits ...………………………………………………………………….. 15
     12. Final Outcome ……………………………………………………………... 20
-
dc.description.tableofcontents TABLE OF CONTENTS
     Abstract ………………………………………………………………………… iii
     Acknowledgements …………………………………………………………… v
     Table of Contents ……………………………………………………………… vi
     1. Story Introduction ……………………………………………………………. 1
     2. Company Background ..……………………………………………………… 2
     3. The Medical Device Industry ...……………………………………………… 2
      3.1 Industry Investment ……………………………………………………. 3
     3.2 Increasing Costs ……………………………………………………….. 4
     3.3 Reimbursement Challenges ……………………………………………. 4
     3.4 Technology Guided Evolution of Healthcare ………………………….. 5
     4. Third Generation Product Lines ……………………………………………... 6
     5. Advanced Medical Home ……………………………………………………. 7
     6. Meeting Break ……………………………………………………………….. 7
     7. The Current Microlife Corporate Brand …………………………………… 8
      7.1 Brand Management .………………………………………………….. 9
      7.2 Centralized control over Global Branding ……………………………. 10
     8. DDG | Direction Design Group LLC, Taiwan Branch ……………………… 10
     8.1 Physician feedback .…………………………………………………. 11
     9. The Next Step | WatchBP …………………………………………………… 12
     10. Discussion Questions ………………………………………………………... 14
     11. Exhibits ...………………………………………………………………….. 15
     12. Final Outcome ……………………………………………………………... 20
zh_TW
dc.language.iso en_US-
dc.source.uri (資料來源) http://thesis.lib.nccu.edu.tw/record/#G0959330291en_US
dc.subject (關鍵詞) 百略醫學科技股份有限公司zh_TW
dc.title (題名) 百略醫學科技股份有限公司:國際品牌、品牌策略個案研究zh_TW
dc.type (資料類型) thesisen
dc.relation.reference (參考文獻) nonezh_TW